The Abuse Deterrent Formulation Technology Market is expected to register a CAGR of XX% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Abuse Deterrent Formulation Technology market report is segmented by drug class into Opioids, Antidepressants, and CNS Stimulants. The abuse deterrence approach segment includes Physical / Chemical Barriers, Agonist / Antagonist Combinations, Aversion Approach, Prodrug Approach, and Abuse-Deterrent Drug Delivery Systems. The product segment includes Tablets, Capsules, Transdermal Patches, and Thin Films. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Abuse Deterrent Formulation Technology Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Abuse Deterrent Formulation Technology Market Segmentation
Drug Class- Opioids
- Antidepressants
- CNS Stimulants
- Physical /Chemical Barriers
- Agonist / Antagonist Combinations
- Aversion Approach
- Prodrug Approach
- Abuse-Deterrent Drug Delivery Systems
- Tablets
- Capsules
- Transdermal Patches
- Thin Films
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Abuse Deterrent Formulation Technology Market Growth Drivers- Rising Prescription Drug Abuse and Misuse: The increasing number of prescription drug abuse and misuse cases, leading to higher overdose death rates and addiction, has created a strong demand for innovative solutions like abuse-deterrent formulations.
- Increased Awareness and Regulatory Actions: Growing awareness among healthcare professionals, policymakers, and the public about the dangers of prescription drug abuse, coupled with stricter regulations from regulatory authorities, is driving the demand for abuse-deterrent products.
- Growing Geriatric Population: The rising geriatric population, which is more likely to suffer from chronic pain and rely on prescription drugs, is contributing to the increased need for abuse-deterrent formulations in the market.
- Developments in Abuse-Deterrent Technologies: Some other major market trends include the developments in abuse-deterrent technologies such as tamper-evident packaging, time-release formulations, and formulations that induce undesirable effects in case of misuse, which further enhance the effectiveness of abuse-deterrent medications.
- Increasing Focus on Patient Education: Increasing focus on patient education and awareness programs that raise warnings against prescription drug abuse is also likely to boost growth in the market.
- Stricter International Regulations and Investment: Since prescription drug abuse is tightening internationally due to the fact that better controls are being introduced by regulatory authorities, it will encourage more investment from pharmaceutical companies with more money for developing innovative formulations in terms of abuse prevention.
- Growing Geriatric Population and Chronic Pain Conditions: With the rising geriatric population and increasing incidence of chronic pain conditions, the market for abuse-deterrent medications is also expanding, offering significant opportunities for growth.
- Supportive Regulatory Environment: The overall supportive regulatory environment, where regulators are actively working to support the research and integration of abuse-deterrent technologies, augurs well for growth in the market.
- Strategic Collaboration for Better Health Outcomes: Strategic collaboration between the pharmaceutical and healthcare industries will promote the use of abuse-deterrent formulations, addressing prescription drug abuse and improving patient health outcomes with significant social and economic impact.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Abuse Deterrent Formulation Technology Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Abuse Deterrent Formulation Technology Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The leading players of the market are: Bayer, TITAN Pharmaceuticals, Pfizer, Orexo, Lonza, Johnson & Johnson, Acura Pharmaceuticals, Daiichi Sankyo, ExxPharma Therapeutics, SunGen Pharma
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Advancement in technology leads to producing even more complex abuse-deterrent formulations, such as tamper-evident packaging and time-release mechanisms, alongside formulation that causes unpleasant effects on misuse. Additionally, the emphasis on patient education and awareness programs concerning the risks of prescription drug abuse will drive the demand for abuse-deterrent products. Pharmaceutical companies worldwide will have to invest a lot in research and development for creating innovative and effective abuse-deterrent formulations as the regulations of regulatory bodies worldwide become stricter.
Abuse Deterrent Formulation Technology Market is expected to grow at a CAGR of XX% between 2023-2031
The major drivers of the Abuse Deterrent Formulation Technology market are the escalating issues related to prescription drug abuse and misuse. The growing numbers of overdose deaths and addiction due to this trend are highly motivating the demand for novel solutions. In addition, increasing regulations from the authorities towards prescription drug abuse make the pharmaceutical companies design and introduce products that have a reduced propensity to be abused. The growing population of geriatrics, which suffers from chronic pain and is almost fully dependent on prescription medicine, further fuels the market's growth. Several optimistic trends mark the future for Abuse Deterrent Formulation Technology.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Abuse Deterrent Formulation Technology Market - By Drug Class
1.3.2 Abuse Deterrent Formulation Technology Market - By Abuse Deterrence Approach
1.3.3 Abuse Deterrent Formulation Technology Market - By Product
1.3.4 Abuse Deterrent Formulation Technology Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1. ABUSE DETERRENT FORMULATION TECHNOLOGY - GLOBAL MARKET OVERVIEW
6.2. ABUSE DETERRENT FORMULATION TECHNOLOGY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. OPIOIDS
7.3.1. Overview
7.3.2. Opioids Market Forecast and Analysis
7.4. ANTIDEPRESSANTS
7.4.1. Overview
7.4.2. Antidepressants Market Forecast and Analysis
7.5. CNS STIMULANTS
7.5.1. Overview
7.5.2. CNS Stimulants Market Forecast and Analysis
8. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - ABUSE DETERRENCE APPROACH
8.1. OVERVIEW
8.2. ABUSE DETERRENCE APPROACH MARKET FORECASTS AND ANALYSIS
8.3. PHYSICAL /CHEMICAL BARRIERS
8.3.1. Overview
8.3.2. Physical /Chemical Barriers Market Forecast and Analysis
8.4. AGONIST / ANTAGONIST COMBINATIONS
8.4.1. Overview
8.4.2. Agonist / Antagonist Combinations Market Forecast and Analysis
8.5. AVERSION APPROACH
8.5.1. Overview
8.5.2. Aversion Approach Market Forecast and Analysis
8.6. PRODRUG APPROACH
8.6.1. Overview
8.6.2. Prodrug Approach Market Forecast and Analysis
8.7. ABUSE-DETERRENT DRUG DELIVERY SYSTEMS
8.7.1. Overview
8.7.2. Abuse-Deterrent Drug Delivery Systems Market Forecast and Analysis
9. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
9.1. OVERVIEW
9.2. PRODUCT MARKET FORECASTS AND ANALYSIS
9.3. TABLETS
9.3.1. Overview
9.3.2. Tablets Market Forecast and Analysis
9.4. CAPSULES
9.4.1. Overview
9.4.2. Capsules Market Forecast and Analysis
9.5. TRANSDERMAL PATCHES
9.5.1. Overview
9.5.2. Transdermal Patches Market Forecast and Analysis
9.6. THIN FILMS
9.6.1. Overview
9.6.2. Thin Films Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Abuse Deterrent Formulation Technology Market Overview
10.1.2 North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.1.3 North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.1.4 North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.1.5 North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.1.6 North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.1.6.1 United States Abuse Deterrent Formulation Technology Market
10.1.6.1.1 United States Abuse Deterrent Formulation Technology Market by Drug Class
10.1.6.1.2 United States Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.1.6.1.3 United States Abuse Deterrent Formulation Technology Market by Product
10.1.6.2 Canada Abuse Deterrent Formulation Technology Market
10.1.6.2.1 Canada Abuse Deterrent Formulation Technology Market by Drug Class
10.1.6.2.2 Canada Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.1.6.2.3 Canada Abuse Deterrent Formulation Technology Market by Product
10.1.6.3 Mexico Abuse Deterrent Formulation Technology Market
10.1.6.3.1 Mexico Abuse Deterrent Formulation Technology Market by Drug Class
10.1.6.3.2 Mexico Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.1.6.3.3 Mexico Abuse Deterrent Formulation Technology Market by Product
10.2. EUROPE
10.2.1 Europe Abuse Deterrent Formulation Technology Market Overview
10.2.2 Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.2.3 Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.2.5 Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.2.6 Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Abuse Deterrent Formulation Technology Market
10.2.6.1.1 Germany Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.1.2 Germany Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.1.3 Germany Abuse Deterrent Formulation Technology Market by Product
10.2.6.2 France Abuse Deterrent Formulation Technology Market
10.2.6.2.1 France Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.2.2 France Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.2.3 France Abuse Deterrent Formulation Technology Market by Product
10.2.6.3 Italy Abuse Deterrent Formulation Technology Market
10.2.6.3.1 Italy Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.3.2 Italy Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.3.3 Italy Abuse Deterrent Formulation Technology Market by Product
10.2.6.4 Spain Abuse Deterrent Formulation Technology Market
10.2.6.4.1 Spain Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.4.2 Spain Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.4.3 Spain Abuse Deterrent Formulation Technology Market by Product
10.2.6.5 United Kingdom Abuse Deterrent Formulation Technology Market
10.2.6.5.1 United Kingdom Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.5.2 United Kingdom Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.5.3 United Kingdom Abuse Deterrent Formulation Technology Market by Product
10.2.6.6 Rest of Europe Abuse Deterrent Formulation Technology Market
10.2.6.6.1 Rest of Europe Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.6.2 Rest of Europe Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.6.3 Rest of Europe Abuse Deterrent Formulation Technology Market by Product
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Abuse Deterrent Formulation Technology Market Overview
10.3.2 Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.3.3 Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.3.5 Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.3.6 Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Abuse Deterrent Formulation Technology Market
10.3.6.1.1 Australia Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.1.2 Australia Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.1.3 Australia Abuse Deterrent Formulation Technology Market by Product
10.3.6.2 China Abuse Deterrent Formulation Technology Market
10.3.6.2.1 China Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.2.2 China Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.2.3 China Abuse Deterrent Formulation Technology Market by Product
10.3.6.3 India Abuse Deterrent Formulation Technology Market
10.3.6.3.1 India Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.3.2 India Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.3.3 India Abuse Deterrent Formulation Technology Market by Product
10.3.6.4 Japan Abuse Deterrent Formulation Technology Market
10.3.6.4.1 Japan Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.4.2 Japan Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.4.3 Japan Abuse Deterrent Formulation Technology Market by Product
10.3.6.5 South Korea Abuse Deterrent Formulation Technology Market
10.3.6.5.1 South Korea Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.5.2 South Korea Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.5.3 South Korea Abuse Deterrent Formulation Technology Market by Product
10.3.6.6 Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market
10.3.6.6.1 Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.6.2 Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.6.3 Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market by Product
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Abuse Deterrent Formulation Technology Market Overview
10.4.2 Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.4.3 Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.4.5 Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.4.6 Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Abuse Deterrent Formulation Technology Market
10.4.6.1.1 South Africa Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.1.2 South Africa Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.1.3 South Africa Abuse Deterrent Formulation Technology Market by Product
10.4.6.2 Saudi Arabia Abuse Deterrent Formulation Technology Market
10.4.6.2.1 Saudi Arabia Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.2.2 Saudi Arabia Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.2.3 Saudi Arabia Abuse Deterrent Formulation Technology Market by Product
10.4.6.3 U.A.E Abuse Deterrent Formulation Technology Market
10.4.6.3.1 U.A.E Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.3.2 U.A.E Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.3.3 U.A.E Abuse Deterrent Formulation Technology Market by Product
10.4.6.4 Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market
10.4.6.4.1 Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.4.2 Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.4.3 Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market by Product
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Abuse Deterrent Formulation Technology Market Overview
10.5.2 South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.5.3 South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.5.5 South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.5.6 South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Abuse Deterrent Formulation Technology Market
10.5.6.1.1 Brazil Abuse Deterrent Formulation Technology Market by Drug Class
10.5.6.1.2 Brazil Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.5.6.1.3 Brazil Abuse Deterrent Formulation Technology Market by Product
10.5.6.2 Argentina Abuse Deterrent Formulation Technology Market
10.5.6.2.1 Argentina Abuse Deterrent Formulation Technology Market by Drug Class
10.5.6.2.2 Argentina Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.5.6.2.3 Argentina Abuse Deterrent Formulation Technology Market by Product
10.5.6.3 Rest of South and Central America Abuse Deterrent Formulation Technology Market
10.5.6.3.1 Rest of South and Central America Abuse Deterrent Formulation Technology Market by Drug Class
10.5.6.3.2 Rest of South and Central America Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.5.6.3.3 Rest of South and Central America Abuse Deterrent Formulation Technology Market by Product
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET, KEY COMPANY PROFILES
12.1. BAYER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TITAN PHARMACEUTICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. OREXO
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LONZA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ACURA PHARMACEUTICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. DAIICHI SANKYO
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EXXPHARMA THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUNGEN PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1.Bayer
2.TITAN Pharmaceuticals
3.Pfizer
4.Orexo
5.Lonza
6.Johnson and Johnson
7.Acura Pharmaceuticals
8.Daiichi Sankyo
9.ExxPharma Therapeutics
10.SunGen Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For